Study Affirms Resveratrol Supports Heart Health

HEERLEN, NetherlandsA new study affirms the beneficial role of resveratrol in the support of cardiovascular health. Presented at the 24th Scientific Meeting of the International Society of Hypertension in Sydney, the results demonstrate regular supplementation with DSM resVida® resveratrol has a positive and sustained effect on circulatory function in obese, mildly hypertensive adults.

The double-blind, placebo-controlled trial was conducted by researchers at the University of South Australia, Adelaide. For the study, 28 subjects were supplemented with 75mg Resvida per day for six weeks. This resulted in a significant 23% increase in vasodilator function (measured by flow-mediated dilatation, FMD), compared with the placebo. The extent of improvement was greater in subjects with poorer initial vasodilator function. This is important as a decreased vasodilator response is an early biomarker for cardiovascular risk and associated with obesity and hypertension.